Aditxt Inc. (ADTX NASDAQ) stock market data APIs
$0.9933
0(0%)
as of September 15, 2025
Try our APIs with
free plan!
Aditxt Inc. Financial Data Overview
Price chart is built with
Anychart
Aditxt, Inc., a commercial-stage company, discovers and develops products in the areas of immune health, precision health, population health, women's health, and neurologic health. The company develops AditxtScore that enable individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. It also develops ADI-100 for skin grafting, psoriasis, type 1 diabetes, and multiple sclerosis. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Mountain View, California.
Prev. Close
0.9933
Open
0.9933
High
1.0106
Low
0.9736
52 wk Range
0.81-4700
Market Cap
5 026 K
P/E Ratio
0.0003
Shares Outstanding
4 977 K
Revenue
12 051
EPS
-3.45
Beta
1.406
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Aditxt Inc. data using free add-ons & libraries
Get Aditxt Inc. Fundamental Data
Aditxt Inc. Fundamental data includes:
- Net Revenue: 12 051
- EBITDA: -21 663 292
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-14
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Aditxt Inc. News
New
Aditxt subsidiary targets early 2026 FDA submission for immune therapy
MOUNTAIN VIEW, Calif. - Aditxt, Inc. (NASDAQ:ADTX) announced Monday that its wholly owned subsidiary Adimune is preparing to seek FDA submission and approval for first-in-human trials in type 1 diabet...
Crypto.com to provide custody for Aditxt's planned digital treasury
MOUNTAIN VIEW, Calif. - Aditxt, Inc. (NASDAQ:ADTX), a micro-cap biotech company with a market capitalization of $5.9 million, has signed a custody agreement with Crypto.com to establish a custodial cr...
Aditxt files to sell up to 50M shares of common stock for holders
* Aditxt (NASDAQ:ADTX [https://seekingalpha.com/symbol/ADTX]) filed to sell up to 50M shares of common stock for holders. * Filing [https://seekingalpha.com/filing/10116216] MORE ON ADITX THERAPE...
Why Aditxt Inc. (ADTX) Went Down On Thursday?
We recently published a list of 10 Stocks Fall Behind Amid Market Optimism. In this article, we are going to take a look at where Aditxt Inc. (NASDAQ:ADTX) stands against other stocks that fall behind...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
